4.0 Article

Association between insulin resistance and total plasma homocysteine levels in type 2 diabetes mellitus patients in south west Nigeria

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.dsx.2017.06.002

Keywords

Homocysteine; Insulin resistance; Type 2 diabetes mellitus; Nigeria

Ask authors/readers for more resources

Aim: To determine the levels of serum homocysteine and its association with insulin resistance among T2DM patients at Obafemi Awolowo University Teaching Hospital, Ile Ife Nigeria. Methods: It was a cross sectional study. It involved consecutive recruitment of 100 T2DM subjects with 100 age and sex matched controls. The fasting plasma glucose, serum creatinine, fasting lipid profile, glycosylated haemoglobin levels, fasting serum insulin and plasma homocysteine concentration were done. Insulin resistance was also determined. SPSS version 17.0 was used for data analysis. Results: The mean age of subjects was not significantly different from controls. (58.9 +/- 8.3 vs. 59.0 +/- 8.3 years, p = 0.926 respectively). Mean Homocysteine level (tHcy) was significantly higher among T2DM subjects compared to controls (27.4 +/- 12.1 and 8.3 +/- 3.2 mmol/L respectively, p = 0.0001). Hyperhomocystinaemia was commoner among diabetic subjects compared with controls (81% vs. 5%, p < 0.0001). T2DM with hyperhomocystinaemia were more likely to have poorer glucose control profile using glycated haemoglobin (7.4 +/- 1.9 vs 6.4 +/- 1.4%, p = 0.04) and fasting blood glucose 8.6 +/- 2.2 vs 7.5 +/- 2.4 mmol/L p = 0.047 and insulin resistance (4.4 +/- 4.3 vs. 2.0 +/- 0.6, p = 0.02) compared with T2DM with normohomocystenaemia. There were significant associations between hyperhomocystinaemic T2DM patients and IR, HbA1c, TC, TG and LDL cholesterol. Conclusion: The study showed higher homocysteine levels in T2DM than controls. Homocysteine level is worsened by increasing insulin resistance, dyslipidaemia and poor glucose control. Homocysteine level is a potential cardiovascular risk marker in type 2 diabetic mellitus subjects. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available